USFDA accepts Eisai’s sBLA and grants priority review for approval of LEQEMBITM Alzheimer’s treatment Read more
Dr Reddy’s Laboratories enters into definitive agreement with Citius Pharmaceuticals to sell its rights to anti-cancer agent E7777 Read more
Eisai, Bristol Myers Squibb enter collaboration for Eisai’s MORAb-202 antibody-drug conjugate Read more